| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | HSPG2 TNC MATN2 LAMA5 TECTA THBS1 THBS2 THBS3 VCAN FBN3 NPNT | 2.37e-08 | 188 | 123 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 TBC1D9B PAMR1 MATN2 CBLB LRP1B F7 CRB1 THBS1 THBS2 EYS THBS3 DST VCAN DLL3 LRP2 FBN3 NOTCH2 OC90 NPNT | 3.14e-08 | 749 | 123 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 ZNF732 ZNF451 ZFP1 TSHZ1 ZNF470 ZNF30 ZNF543 PRDM15 NOTCH2 ZNF292 ZNF646 | 3.81e-07 | 1412 | 123 | 26 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 EHMT2 ZNF732 ZNF277 ZNF335 ZFP1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF646 | 2.47e-06 | 1459 | 123 | 25 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF148 ZNF154 ZFP3 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF263 ZNF732 ZNF277 ZNF335 ZFP1 ZNF470 ZNF30 ZNF543 PRDM15 NOTCH2 ZNF646 | 2.72e-06 | 1271 | 123 | 23 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF148 ZNF154 ZFP3 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF263 ZNF732 ZNF277 ZNF335 ZFP1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF646 | 6.70e-06 | 1244 | 123 | 22 | GO:0000978 |
| GeneOntologyMolecularFunction | integrin binding | 1.07e-04 | 175 | 123 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.20e-04 | 16 | 123 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.80e-04 | 21 | 123 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | collagen V binding | 3.72e-04 | 5 | 123 | 2 | GO:0070052 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 4.23e-04 | 102 | 123 | 5 | GO:0001540 | |
| GeneOntologyMolecularFunction | structural molecule activity | HSPG2 TNC MATN2 LAMA5 TECTA RPL10A THBS1 THBS2 THBS3 DST VCAN FBN3 OC90 NPNT | 1.18e-03 | 891 | 123 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | protein phosphatase 1 binding | 1.29e-03 | 35 | 123 | 3 | GO:0008157 | |
| GeneOntologyMolecularFunction | collagen binding | 1.58e-03 | 81 | 123 | 4 | GO:0005518 | |
| GeneOntologyMolecularFunction | fibronectin binding | 1.64e-03 | 38 | 123 | 3 | GO:0001968 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | EPHB2 HSPG2 ERBB2 ERBB4 TNC LILRB2 ITGA2 CR1 ITGAX PPP1CC BLM CNBP KMT2C THBS1 IGFBP5 ZNF335 VCAN LRP2 PHIP NOTCH2 PRAMEF11 | 6.20e-06 | 1190 | 122 | 21 | GO:0008284 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | SPRED3 THBS1 ZFYVE9 ZNF451 VWC2L LRP2 NOTCH2 SMAD6 NPNT SORL1 | 4.15e-05 | 347 | 122 | 10 | GO:0090092 |
| GeneOntologyBiologicalProcess | axon guidance | 5.05e-05 | 285 | 122 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 5.19e-05 | 286 | 122 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | SPRED3 ZIC2 THBS1 ZFYVE9 ZNF451 VWC2L LRP2 NOTCH2 SMAD6 NPNT SORL1 | 6.82e-05 | 445 | 122 | 11 | GO:0141091 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | HSPG2 MATN2 ITGA2 PRDM5 ADAMTSL3 P3H4 PTX3 ADAMTS17 LOXL4 NPNT | 8.29e-05 | 377 | 122 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | HSPG2 MATN2 ITGA2 PRDM5 ADAMTSL3 P3H4 PTX3 ADAMTS17 LOXL4 NPNT | 8.47e-05 | 378 | 122 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | HSPG2 MATN2 ITGA2 PRDM5 ADAMTSL3 P3H4 PTX3 ADAMTS17 LOXL4 NPNT | 8.66e-05 | 379 | 122 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | embryo development | EPHB2 HSPG2 ERBB4 POLE LAMA5 TECTA CR1 LRP1B ZIC2 PPP1CC LIMS1 GJB5 ZNF335 DLL3 LRP2 TSHZ1 ADGRF4 NOTCH2 PRAMEF11 SMAD6 WDTC1 | 1.00e-04 | 1437 | 122 | 21 | GO:0009790 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | SPRED3 ZIC2 THBS1 ZFYVE9 ZNF451 VWC2L LRP2 NOTCH2 SMAD6 NPNT SORL1 | 1.38e-04 | 482 | 122 | 11 | GO:0007178 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | EPHB2 HSPG2 ERBB4 TNC LAMA5 ITGA2 TECTA ITGAX CRB1 THBS1 THBS3 LIMS1 IGFBP5 ZNF335 LRP2 TSHZ1 NOTCH2 SMAD6 NPNT | 1.64e-04 | 1269 | 122 | 19 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | SPRED3 THBS1 ZFYVE9 ZNF451 VWC2L LRP2 NOTCH2 SMAD6 NPNT SORL1 | 1.71e-04 | 412 | 122 | 10 | GO:0090287 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | EPHB2 ERBB2 ERBB4 CBLB F7 SPRED3 ZIC2 THBS1 ZFYVE9 IGFBP5 ZNF451 VWC2L LRP2 PHIP NOTCH2 SMAD6 NPNT SORL1 | 2.10e-04 | 1186 | 122 | 18 | GO:0007167 |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 TNC MATN2 LAMA5 TECTA ADAMTSL3 F7 THBS1 THBS2 EYS THBS3 DST PTX3 VCAN ADAMTS17 LOXL4 FBN3 OC90 NPNT | 1.11e-08 | 656 | 124 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 TNC MATN2 LAMA5 TECTA ADAMTSL3 F7 THBS1 THBS2 EYS THBS3 DST PTX3 VCAN ADAMTS17 LOXL4 FBN3 OC90 NPNT | 1.17e-08 | 658 | 124 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 TNC MATN2 LAMA5 F7 THBS1 THBS2 EYS THBS3 DST VCAN ADAMTS17 LOXL4 NPNT | 3.24e-06 | 530 | 124 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 8.30e-06 | 122 | 124 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 5.58e-05 | 13 | 124 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 5.15e-04 | 6 | 124 | 2 | GO:0033165 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 7.19e-04 | 7 | 124 | 2 | GO:0072357 | |
| GeneOntologyCellularComponent | glycogen granule | 9.55e-04 | 8 | 124 | 2 | GO:0042587 | |
| Domain | EGF-like_dom | HSPG2 PAMR1 TNC MATN2 LAMA5 TECTA LRP1B F7 CRB1 THBS1 THBS2 EYS THBS3 VCAN DLL3 LRP2 C8B FBN3 NOTCH2 NPNT SORL1 | 1.33e-17 | 249 | 123 | 21 | IPR000742 |
| Domain | EGF_2 | EPHB2 HSPG2 PAMR1 TNC MATN2 LAMA5 LRP1B F7 CRB1 THBS1 THBS2 EYS THBS3 VCAN DLL3 LRP2 C8B FBN3 NOTCH2 NPNT SORL1 | 4.77e-17 | 265 | 123 | 21 | PS01186 |
| Domain | EGF | HSPG2 PAMR1 TNC MATN2 LAMA5 TECTA LRP1B F7 CRB1 THBS1 THBS2 EYS THBS3 VCAN DLL3 LRP2 FBN3 NOTCH2 NPNT SORL1 | 7.02e-17 | 235 | 123 | 20 | SM00181 |
| Domain | Znf_C2H2 | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 RNF114 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 PRDM10 ZNF276 GTF3A ZNF732 ZNF277 ZNF451 ZNF335 ZFP1 ADAMTS17 TSHZ1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF292 ZNF646 | 9.01e-17 | 805 | 123 | 32 | IPR007087 |
| Domain | EGF_CA | HSPG2 PAMR1 MATN2 LRP1B F7 CRB1 THBS1 THBS2 EYS THBS3 VCAN DLL3 LRP2 FBN3 NOTCH2 NPNT | 1.05e-16 | 122 | 123 | 16 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 PAMR1 MATN2 LRP1B F7 CRB1 THBS1 THBS2 EYS THBS3 VCAN DLL3 LRP2 FBN3 NOTCH2 NPNT | 1.38e-16 | 124 | 123 | 16 | IPR001881 |
| Domain | Growth_fac_rcpt_ | EPHB2 HSPG2 ERBB2 ERBB4 TNC MATN2 LAMA5 LRP1B CRB1 EYS THBS3 IGFBP5 DLL3 LRP2 FBN3 NOTCH2 NPNT | 2.69e-16 | 156 | 123 | 17 | IPR009030 |
| Domain | EGF-like_CS | HSPG2 PAMR1 TNC MATN2 LAMA5 LRP1B F7 CRB1 THBS1 THBS2 EYS THBS3 VCAN DLL3 LRP2 C8B FBN3 NOTCH2 NPNT SORL1 | 5.43e-16 | 261 | 123 | 20 | IPR013032 |
| Domain | ZnF_C2H2 | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 RNF114 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 PRDM10 ZNF276 GTF3A ZNF732 ZNF277 ZNF451 ZNF335 ZFP1 TSHZ1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF292 ZNF646 | 8.03e-16 | 808 | 123 | 31 | SM00355 |
| Domain | zf-C2H2 | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 PRDM10 ZNF276 GTF3A ZNF732 ZNF277 ZNF451 ZNF335 ZFP1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF292 ZNF646 | 8.63e-16 | 693 | 123 | 29 | PF00096 |
| Domain | EGF_3 | HSPG2 PAMR1 TNC MATN2 LRP1B F7 CRB1 THBS1 THBS2 EYS THBS3 VCAN DLL3 LRP2 C8B FBN3 NOTCH2 NPNT SORL1 | 1.15e-15 | 235 | 123 | 19 | PS50026 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 PRDM10 ZNF276 GTF3A ZNF732 ZNF277 ZNF451 ZNF335 ZFP1 TSHZ1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF292 ZNF646 | 2.03e-15 | 775 | 123 | 30 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 PRDM10 ZNF276 GTF3A ZNF732 ZNF277 ZNF451 ZNF335 ZFP1 TSHZ1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF292 ZNF646 | 2.17e-15 | 777 | 123 | 30 | PS00028 |
| Domain | Znf_C2H2-like | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF227 ZNF317 ZNF236 RNF114 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 PRDM10 ZNF276 GTF3A ZNF732 ZNF277 ZNF451 ZNF335 ZFP1 TSHZ1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF292 ZNF646 | 4.14e-15 | 796 | 123 | 30 | IPR015880 |
| Domain | EGF | HSPG2 PAMR1 TNC MATN2 TECTA LRP1B F7 CRB1 THBS2 EYS VCAN DLL3 LRP2 FBN3 NOTCH2 | 4.41e-15 | 126 | 123 | 15 | PF00008 |
| Domain | EGF_1 | HSPG2 PAMR1 TNC LAMA5 LRP1B F7 CRB1 THBS1 THBS2 EYS THBS3 VCAN DLL3 LRP2 C8B FBN3 NOTCH2 NPNT | 7.29e-14 | 255 | 123 | 18 | PS00022 |
| Domain | - | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 PRDM10 ZNF276 GTF3A ZNF732 ZNF335 ZFP1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF292 ZNF646 | 2.65e-13 | 679 | 123 | 26 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 PRDM10 ZNF276 GTF3A ZNF732 ZNF335 ZFP1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF292 ZNF646 | 4.37e-13 | 694 | 123 | 26 | IPR013087 |
| Domain | EGF_Ca-bd_CS | 8.22e-10 | 97 | 123 | 10 | IPR018097 | |
| Domain | EGF_CA | 1.01e-09 | 99 | 123 | 10 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.11e-09 | 100 | 123 | 10 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.98e-09 | 106 | 123 | 10 | IPR000152 | |
| Domain | EGF_CA | 5.21e-09 | 86 | 123 | 9 | PF07645 | |
| Domain | - | 1.27e-08 | 95 | 123 | 9 | 2.60.120.200 | |
| Domain | ConA-like_dom | HSPG2 TMPRSS15 TRIM41 LAMA5 CRB1 THBS1 THBS2 EYS THBS3 PTX3 PAPPA NPNT | 2.29e-08 | 219 | 123 | 12 | IPR013320 |
| Domain | KRAB | ZNF154 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF496 ZNF19 ZNF263 ZNF732 ZFP1 ZNF470 ZNF30 ZNF543 | 1.03e-07 | 358 | 123 | 14 | PS50805 |
| Domain | KRAB | ZNF154 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF496 ZNF19 ZNF263 ZNF732 ZFP1 ZNF470 ZNF30 ZNF543 | 1.03e-07 | 358 | 123 | 14 | PF01352 |
| Domain | Laminin_G | 1.03e-07 | 58 | 123 | 7 | IPR001791 | |
| Domain | KRAB | ZNF154 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF496 ZNF19 ZNF263 ZNF732 ZFP1 ZNF470 ZNF30 ZNF543 | 1.49e-07 | 369 | 123 | 14 | SM00349 |
| Domain | KRAB | ZNF154 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF496 ZNF19 ZNF263 ZNF732 ZFP1 ZNF470 ZNF30 ZNF543 | 1.54e-07 | 370 | 123 | 14 | IPR001909 |
| Domain | LDLR_class-A_CS | 2.31e-07 | 40 | 123 | 6 | IPR023415 | |
| Domain | Ldl_recept_a | 4.76e-07 | 45 | 123 | 6 | PF00057 | |
| Domain | LDLRA_1 | 7.06e-07 | 48 | 123 | 6 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 8.00e-07 | 49 | 123 | 6 | IPR002172 | |
| Domain | LDLa | 8.00e-07 | 49 | 123 | 6 | SM00192 | |
| Domain | LDLRA_2 | 8.00e-07 | 49 | 123 | 6 | PS50068 | |
| Domain | hEGF | 9.94e-07 | 28 | 123 | 5 | PF12661 | |
| Domain | zf-C2H2_6 | ZNF154 ZFP28 ZNF227 ZNF317 ZNF236 PRDM5 ZNF883 PRDM10 ZNF732 ZNF30 ZNF543 ZNF646 | 1.12e-06 | 314 | 123 | 12 | PF13912 |
| Domain | TSP_3 | 2.76e-06 | 5 | 123 | 3 | PF02412 | |
| Domain | TSP3 | 2.76e-06 | 5 | 123 | 3 | PS51234 | |
| Domain | TSP_CTER | 2.76e-06 | 5 | 123 | 3 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 2.76e-06 | 5 | 123 | 3 | IPR017897 | |
| Domain | TSP_type-3_rpt | 2.76e-06 | 5 | 123 | 3 | IPR028974 | |
| Domain | - | 2.76e-06 | 5 | 123 | 3 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 2.76e-06 | 5 | 123 | 3 | IPR008859 | |
| Domain | TSP_C | 2.76e-06 | 5 | 123 | 3 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 2.76e-06 | 5 | 123 | 3 | IPR003367 | |
| Domain | - | 1.26e-05 | 46 | 123 | 5 | 4.10.400.10 | |
| Domain | SET_dom | 1.91e-05 | 50 | 123 | 5 | IPR001214 | |
| Domain | SET | 1.91e-05 | 50 | 123 | 5 | PS50280 | |
| Domain | Sushi | 2.32e-05 | 52 | 123 | 5 | PF00084 | |
| Domain | cEGF | 2.39e-05 | 26 | 123 | 4 | PF12662 | |
| Domain | cEGF | 2.39e-05 | 26 | 123 | 4 | IPR026823 | |
| Domain | CCP | 2.79e-05 | 54 | 123 | 5 | SM00032 | |
| Domain | SUSHI | 3.33e-05 | 56 | 123 | 5 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 3.63e-05 | 57 | 123 | 5 | IPR000436 | |
| Domain | TSP_1 | 5.91e-05 | 63 | 123 | 5 | PF00090 | |
| Domain | TSP1 | 6.88e-05 | 65 | 123 | 5 | SM00209 | |
| Domain | TSP1_rpt | 6.88e-05 | 65 | 123 | 5 | IPR000884 | |
| Domain | TSP1 | 6.88e-05 | 65 | 123 | 5 | PS50092 | |
| Domain | Ldl_recept_b | 9.62e-05 | 14 | 123 | 3 | PF00058 | |
| Domain | LDLRB | 9.62e-05 | 14 | 123 | 3 | PS51120 | |
| Domain | VWFC_2 | 1.11e-04 | 38 | 123 | 4 | PS50184 | |
| Domain | VWC | 1.11e-04 | 38 | 123 | 4 | SM00214 | |
| Domain | LAM_G_DOMAIN | 1.11e-04 | 38 | 123 | 4 | PS50025 | |
| Domain | LY | 1.20e-04 | 15 | 123 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.20e-04 | 15 | 123 | 3 | IPR000033 | |
| Domain | STPPase_N | 1.29e-04 | 3 | 123 | 2 | IPR031675 | |
| Domain | STPPase_N | 1.29e-04 | 3 | 123 | 2 | PF16891 | |
| Domain | Laminin_G_2 | 1.36e-04 | 40 | 123 | 4 | PF02210 | |
| Domain | VWF_dom | 1.65e-04 | 42 | 123 | 4 | IPR001007 | |
| Domain | LamG | 1.98e-04 | 44 | 123 | 4 | SM00282 | |
| Domain | SET | 2.36e-04 | 46 | 123 | 4 | SM00317 | |
| Domain | LamGL | 2.56e-04 | 4 | 123 | 2 | SM00560 | |
| Domain | LamG-like | 2.56e-04 | 4 | 123 | 2 | IPR006558 | |
| Domain | Tyr_kinase_EGF/ERB/XmrK_rcpt | 2.56e-04 | 4 | 123 | 2 | IPR016245 | |
| Domain | SRCR | 3.40e-04 | 21 | 123 | 3 | PF00530 | |
| Domain | Znf_C2H2_jaz | 3.92e-04 | 22 | 123 | 3 | IPR022755 | |
| Domain | zf-C2H2_jaz | 3.92e-04 | 22 | 123 | 3 | PF12171 | |
| Domain | TSPN | 4.48e-04 | 23 | 123 | 3 | SM00210 | |
| Domain | - | 5.77e-04 | 25 | 123 | 3 | 3.10.250.10 | |
| Domain | SR | 5.77e-04 | 25 | 123 | 3 | SM00202 | |
| Domain | GF_recep_IV | 6.34e-04 | 6 | 123 | 2 | PF14843 | |
| Domain | GF_recep_IV | 6.34e-04 | 6 | 123 | 2 | IPR032778 | |
| Domain | Methyltransf_12 | 6.34e-04 | 6 | 123 | 2 | IPR013217 | |
| Domain | Methyltransf_12 | 6.34e-04 | 6 | 123 | 2 | PF08242 | |
| Domain | SRCR-like_dom | 6.49e-04 | 26 | 123 | 3 | IPR017448 | |
| Domain | SRCR_1 | 6.49e-04 | 26 | 123 | 3 | PS00420 | |
| Domain | SRCR_2 | 6.49e-04 | 26 | 123 | 3 | PS50287 | |
| Domain | EGF_extracell | 6.57e-04 | 60 | 123 | 4 | IPR013111 | |
| Domain | EGF_2 | 6.57e-04 | 60 | 123 | 4 | PF07974 | |
| Domain | SRCR | 7.26e-04 | 27 | 123 | 3 | IPR001190 | |
| Domain | Notch_dom | 8.84e-04 | 7 | 123 | 2 | IPR000800 | |
| Domain | Recep_L_domain | 8.84e-04 | 7 | 123 | 2 | PF01030 | |
| Domain | Furin-like | 8.84e-04 | 7 | 123 | 2 | PF00757 | |
| Domain | Rcpt_L-dom | 8.84e-04 | 7 | 123 | 2 | IPR000494 | |
| Domain | Furin-like_Cys-rich_dom | 8.84e-04 | 7 | 123 | 2 | IPR006211 | |
| Domain | Notch | 8.84e-04 | 7 | 123 | 2 | PF00066 | |
| Domain | - | 8.84e-04 | 7 | 123 | 2 | 3.80.20.20 | |
| Domain | NL | 8.84e-04 | 7 | 123 | 2 | SM00004 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.20e-06 | 84 | 92 | 7 | M7098 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 2.98e-06 | 96 | 92 | 7 | M39581 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.35e-06 | 66 | 92 | 6 | M18 | |
| Pathway | WP_FOCAL_ADHESION | 5.87e-06 | 199 | 92 | 9 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.87e-06 | 199 | 92 | 9 | M7253 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.92e-06 | 76 | 92 | 6 | M27219 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.53e-05 | 300 | 92 | 10 | M610 | |
| Pathway | WP_FOCAL_ADHESION | 2.97e-05 | 187 | 92 | 8 | MM15913 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.02e-05 | 59 | 92 | 5 | M27218 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.07e-05 | 143 | 92 | 7 | M27275 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 8.00e-05 | 68 | 92 | 5 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.17e-04 | 39 | 92 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.17e-04 | 39 | 92 | 4 | MM15165 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ERBB2 ZNF154 ZNF559 ZFP28 ZNF227 ZNF317 CR1 ZNF496 BLM KMT2C ZNF19 ZNF263 THBS1 EHMT2 ZNF732 ZFP1 ZNF470 ZNF30 ZNF543 NOTCH2 SMAD6 | 1.88e-04 | 1387 | 92 | 21 | M734 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.26e-04 | 250 | 92 | 8 | M27554 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.31e-04 | 85 | 92 | 5 | M16441 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 2.44e-04 | 86 | 92 | 5 | M2642 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.44e-04 | 47 | 92 | 4 | MM14925 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 6.27e-04 | 26 | 92 | 3 | M628 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 7.02e-04 | 27 | 92 | 3 | M27217 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 9.61e-04 | 30 | 92 | 3 | M27216 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.61e-04 | 30 | 92 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 9.61e-04 | 30 | 92 | 3 | MM15812 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE | 1.15e-03 | 8 | 92 | 2 | M47933 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.62e-09 | 248 | 124 | 11 | 24006456 | |
| Pubmed | 2.54e-08 | 50 | 124 | 6 | 23658023 | ||
| Pubmed | ZNF148 ZFP28 PHF8 ZNF236 RNF114 PRDM5 ZNF496 ZNF263 LIMS1 GTF3A ZNF277 ZNF451 KAT6B MBNL3 ZNF292 ZNF646 | 3.28e-08 | 808 | 124 | 16 | 20412781 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 34669362 | ||
| Pubmed | Thrombospondin 1 and thrombospondin 2 are expressed as both homo- and heterotrimers. | 4.42e-08 | 3 | 124 | 3 | 1459996 | |
| Pubmed | Differential expression of thrombospondin 1, 2, and 3 during murine development. | 4.42e-08 | 3 | 124 | 3 | 8400410 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 9373030 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 8.04e-08 | 101 | 124 | 7 | 23382219 | |
| Pubmed | 1.64e-07 | 167 | 124 | 8 | 22159717 | ||
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 1.76e-07 | 4 | 124 | 3 | 6338048 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 ERBB2 RIN3 TBC1D9B POLE LAMA5 ZNF236 KMT2C ZNF263 FASN URB1 ZNF276 DST MROH1 ZNF335 ULK2 NOTCH2 | 4.29e-07 | 1105 | 124 | 17 | 35748872 |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 30622267 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 5.86e-07 | 135 | 124 | 7 | 28675934 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 6.77e-07 | 86 | 124 | 6 | 28327460 | |
| Pubmed | 9.93e-07 | 146 | 124 | 7 | 27068509 | ||
| Pubmed | 1.36e-06 | 153 | 124 | 7 | 25037231 | ||
| Pubmed | HSPG2 EVC2 LAMA5 CBLB PPP1CA PPP1CC DST ZFYVE9 ZNF451 PAPPA NOTCH2 SMAD6 | 1.47e-06 | 591 | 124 | 12 | 15231748 | |
| Pubmed | 1.53e-06 | 7 | 124 | 3 | 37174615 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.75e-06 | 101 | 124 | 6 | 20551380 | |
| Pubmed | ERBB2 ERBB4 ZNF148 PHF8 PRDM5 P3H4 ZIC2 EHMT2 ZFP1 LRP2 KAT6B PHIP NOTCH2 SORL1 WDTC1 ZNF646 | 2.40e-06 | 1116 | 124 | 16 | 31753913 | |
| Pubmed | Thrombospondins 1 and 2 are important for afferent synapse formation and function in the inner ear. | 2.45e-06 | 8 | 124 | 3 | 24460873 | |
| Pubmed | 3.42e-06 | 64 | 124 | 5 | 22261194 | ||
| Pubmed | AKAP6 ZNF148 ZFP3 TNC ZNF559 ITGA2 RPL10A BLM CNBP KMT2C GTF3A DST BTD VCAN ZFP1 ADGRF4 PRIMPOL | 3.61e-06 | 1293 | 124 | 17 | 15342556 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 HSPG2 ERBB2 HSPA4L MATN2 LAMA5 ITGA2 LRP1B P3H4 TXNL1 THBS1 THBS3 BTD TTC13 NOTCH2 SORL1 | 6.08e-06 | 1201 | 124 | 16 | 35696571 |
| Pubmed | β-Catenin regulates endocardial cushion growth by suppressing p21. | 7.40e-06 | 35 | 124 | 4 | 37385754 | |
| Pubmed | ZFP28 ZNF275 RNF114 CNBP KMT2C THBS3 LDB3 ZNF276 GTF3A KAT6B PHIP ZNF292 | 9.34e-06 | 709 | 124 | 12 | 22988430 | |
| Pubmed | Alpha9 and beta8 integrin expression correlates with the merger of the developing mouse eyelids. | 9.51e-06 | 12 | 124 | 3 | 10090148 | |
| Pubmed | 9.51e-06 | 12 | 124 | 3 | 10830164 | ||
| Pubmed | 1.10e-05 | 210 | 124 | 7 | 16537572 | ||
| Pubmed | 1.23e-05 | 13 | 124 | 3 | 12682087 | ||
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 1.26e-05 | 2 | 124 | 2 | 16181801 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17620335 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 16493581 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 34425286 | ||
| Pubmed | Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system. | 1.26e-05 | 2 | 124 | 2 | 20022944 | |
| Pubmed | Modulation of thrombospondin expression during differentiation of embryonal carcinoma cells. | 1.26e-05 | 2 | 124 | 2 | 8126073 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26107737 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15685397 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9694593 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25674245 | ||
| Pubmed | Characterization of EGFR family gene aberrations in cholangiocarcinoma. | 1.26e-05 | 2 | 124 | 2 | 24927194 | |
| Pubmed | Expression of thrombospondin-1 in ischemia-induced retinal neovascularization. | 1.26e-05 | 2 | 124 | 2 | 10027393 | |
| Pubmed | Extracellular matrix changes in corneal opacification vary depending on etiology. | 1.26e-05 | 2 | 124 | 2 | 33633437 | |
| Pubmed | Corneal stromal cells (keratocytes) express thrombospondins 2 and 3 in wound repair phenotype. | 1.26e-05 | 2 | 124 | 2 | 11943589 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18608122 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22699492 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27714708 | ||
| Pubmed | Expression and initial characterization of recombinant mouse thrombospondin 1 and thrombospondin 3. | 1.26e-05 | 2 | 124 | 2 | 8654563 | |
| Pubmed | Relative abundance of thrombospondin 2 and thrombospondin 3 mRNAs in human tissues. | 1.26e-05 | 2 | 124 | 2 | 10329465 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15235125 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33981184 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 30928339 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23568740 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9882500 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18528705 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 31923801 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17143334 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12083416 | ||
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 1.26e-05 | 2 | 124 | 2 | 23660684 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 39122122 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 25393858 | ||
| Pubmed | Thrombospondin-1 (TSP1)-null and TSP2-null mice exhibit lower intraocular pressures. | 1.26e-05 | 2 | 124 | 2 | 22930728 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27487140 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23419663 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 38339060 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33372257 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 21762961 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33529444 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12213711 | ||
| Pubmed | PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells. | 1.26e-05 | 2 | 124 | 2 | 23176181 | |
| Pubmed | Thrombospondin expression in aldosterone-producing adenomas. | 1.26e-05 | 2 | 124 | 2 | 12358136 | |
| Pubmed | A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. | 1.26e-05 | 2 | 124 | 2 | 1712771 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 19244516 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 37063077 | ||
| Pubmed | Thrombospondin 3 is a developmentally regulated heparin binding protein. | 1.26e-05 | 2 | 124 | 2 | 8288588 | |
| Pubmed | Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. | 1.26e-05 | 2 | 124 | 2 | 18594557 | |
| Pubmed | Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis. | 1.26e-05 | 2 | 124 | 2 | 15037577 | |
| Pubmed | FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration. | 1.26e-05 | 2 | 124 | 2 | 26936618 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 27403446 | ||
| Pubmed | Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer. | 1.26e-05 | 2 | 124 | 2 | 25433947 | |
| Pubmed | Collaborating functions of BLM and DNA topoisomerase I in regulating human rDNA transcription. | 1.26e-05 | 2 | 124 | 2 | 23261817 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 15073129 | ||
| Pubmed | Circulating Levels of Thrombospondin-1 and Thrombospondin-2 in Patients with Common Brain Tumors. | 1.26e-05 | 2 | 124 | 2 | 33759165 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 20053631 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 2.09e-05 | 420 | 124 | 9 | 28065597 | |
| Pubmed | Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. | 2.39e-05 | 16 | 124 | 3 | 21067603 | |
| Pubmed | 2.90e-05 | 17 | 124 | 3 | 22183742 | ||
| Pubmed | 2.90e-05 | 17 | 124 | 3 | 7557990 | ||
| Pubmed | Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. | 3.47e-05 | 18 | 124 | 3 | 19686679 | |
| Pubmed | 3.65e-05 | 52 | 124 | 4 | 28775156 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 26241338 | ||
| Pubmed | Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. | 3.77e-05 | 3 | 124 | 2 | 18787106 | |
| Pubmed | Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas. | 3.77e-05 | 3 | 124 | 2 | 19147558 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 37060105 | ||
| Pubmed | IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis. | 3.77e-05 | 3 | 124 | 2 | 36949068 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 18032585 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 18211286 | ||
| Pubmed | Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin. | 3.77e-05 | 3 | 124 | 2 | 22184199 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 19669783 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 30684846 | ||
| Interaction | GLI4 interactions | 9.92e-07 | 125 | 123 | 8 | int:GLI4 | |
| Interaction | ZSCAN21 interactions | 1.19e-06 | 128 | 123 | 8 | int:ZSCAN21 | |
| Interaction | GLI3 interactions | 2.32e-06 | 98 | 123 | 7 | int:GLI3 | |
| Interaction | ZNF408 interactions | 3.03e-06 | 145 | 123 | 8 | int:ZNF408 | |
| Interaction | ZNF224 interactions | 5.94e-06 | 20 | 123 | 4 | int:ZNF224 | |
| Interaction | PRG2 interactions | 1.01e-05 | 285 | 123 | 10 | int:PRG2 | |
| Interaction | ZNF275 interactions | 1.07e-05 | 23 | 123 | 4 | int:ZNF275 | |
| Interaction | ABT1 interactions | TRIM41 ZNF275 PRDM5 PPP1CC APOBEC3F RPL10A BLM CNBP URB1 PRDM10 PRDM15 SORL1 | 1.10e-05 | 423 | 123 | 12 | int:ABT1 |
| Interaction | CFC1 interactions | 1.23e-05 | 126 | 123 | 7 | int:CFC1 | |
| Interaction | NTN5 interactions | 1.28e-05 | 24 | 123 | 4 | int:NTN5 | |
| Interaction | SIRPD interactions | 1.44e-05 | 86 | 123 | 6 | int:SIRPD | |
| Interaction | KLF9 interactions | 2.26e-05 | 93 | 123 | 6 | int:KLF9 | |
| Interaction | ZFP41 interactions | 2.54e-05 | 57 | 123 | 5 | int:ZFP41 | |
| Interaction | NPNT interactions | 3.53e-05 | 11 | 123 | 3 | int:NPNT | |
| Interaction | ZNF48 interactions | 3.64e-05 | 149 | 123 | 7 | int:ZNF48 | |
| Interaction | LGALS1 interactions | 3.72e-05 | 332 | 123 | 10 | int:LGALS1 | |
| Interaction | TAFAZZIN interactions | 4.06e-05 | 207 | 123 | 8 | int:TAFAZZIN | |
| Interaction | PPP1R3A interactions | 4.81e-05 | 65 | 123 | 5 | int:PPP1R3A | |
| Interaction | NOTCH2 interactions | EPHB2 ZNF275 ASB14 ZNF317 ZNF263 ZNF276 ZNF335 ADAMTS17 NOTCH2 NPNT ZNF646 | 5.74e-05 | 423 | 123 | 11 | int:NOTCH2 |
| Interaction | NDP interactions | 5.98e-05 | 35 | 123 | 4 | int:NDP | |
| Interaction | IGFL3 interactions | 9.57e-05 | 75 | 123 | 5 | int:IGFL3 | |
| Interaction | CCN2 interactions | 1.02e-04 | 40 | 123 | 4 | int:CCN2 | |
| Interaction | COQ4 interactions | 1.02e-04 | 40 | 123 | 4 | int:COQ4 | |
| Interaction | ZNF264 interactions | 1.12e-04 | 41 | 123 | 4 | int:ZNF264 | |
| Interaction | PRDM5 interactions | 1.30e-04 | 80 | 123 | 5 | int:PRDM5 | |
| Interaction | GPX1 interactions | 1.38e-04 | 81 | 123 | 5 | int:GPX1 | |
| Interaction | ALB interactions | 1.44e-04 | 391 | 123 | 10 | int:ALB | |
| Interaction | PI15 interactions | 1.55e-04 | 83 | 123 | 5 | int:PI15 | |
| Interaction | CBX3 interactions | ZNF148 ZNF227 ZNF496 BLM ZNF263 FASN PRDM10 EHMT2 ZNF451 ZFP1 PHIP ZNF292 ZNF646 | 1.62e-04 | 646 | 123 | 13 | int:CBX3 |
| Interaction | PIGR interactions | 1.67e-04 | 133 | 123 | 6 | int:PIGR | |
| Interaction | THBS2 interactions | 2.00e-04 | 19 | 123 | 3 | int:THBS2 | |
| Interaction | PPP1R2C interactions | 2.20e-04 | 4 | 123 | 2 | int:PPP1R2C | |
| Interaction | FOXD4L6 interactions | 2.26e-04 | 49 | 123 | 4 | int:FOXD4L6 | |
| Interaction | TIMP3 interactions | 2.27e-04 | 90 | 123 | 5 | int:TIMP3 | |
| Interaction | FBN1 interactions | 2.65e-04 | 51 | 123 | 4 | int:FBN1 | |
| Interaction | EGFL6 interactions | 2.72e-04 | 21 | 123 | 3 | int:EGFL6 | |
| Cytoband | 3q21 | 1.92e-03 | 24 | 124 | 2 | 3q21 | |
| Cytoband | 19p13 | 2.43e-03 | 27 | 124 | 2 | 19p13 | |
| Cytoband | 19q13 | 3.20e-03 | 31 | 124 | 2 | 19q13 | |
| Cytoband | 6p12.1 | 3.62e-03 | 33 | 124 | 2 | 6p12.1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF148 ZNF154 ZFP3 ZNF559 ZFP28 ZNF275 ZNF227 ZNF317 ZNF236 PRDM5 ZNF496 ZNF883 ZIC2 ZNF19 ZNF263 PRDM10 ZNF276 GTF3A ZNF732 ZNF451 ZNF335 ZFP1 TSHZ1 ZNF470 ZNF30 ZNF543 PRDM15 ZNF292 ZNF646 | 8.54e-18 | 718 | 99 | 29 | 28 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.49e-05 | 57 | 99 | 5 | 1179 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.02e-04 | 17 | 99 | 3 | 1197 | |
| GeneFamily | Erb-b2 receptor tyrosine kinases | 1.77e-04 | 4 | 99 | 2 | 1096 | |
| GeneFamily | Complement system|Sushi domain containing | 9.97e-04 | 36 | 99 | 3 | 492 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 2.23e-03 | 13 | 99 | 2 | 693 | |
| GeneFamily | Low density lipoprotein receptors | 2.23e-03 | 13 | 99 | 2 | 634 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 4.29e-03 | 18 | 99 | 2 | 498 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 4.29e-03 | 18 | 99 | 2 | 1160 | |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 TNC MATN2 LAMA5 TECTA THBS1 THBS2 EYS THBS3 IGFBP5 VCAN FBN3 NPNT | 6.84e-10 | 275 | 124 | 13 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | TNC MATN2 LAMA5 TECTA THBS1 THBS2 EYS THBS3 IGFBP5 FBN3 NPNT | 2.50e-09 | 196 | 124 | 11 | M3008 |
| Coexpression | NABA_MATRISOME | HSPG2 TMPRSS15 PAMR1 TNC MATN2 CST9L LAMA5 TECTA ADAMTSL3 F7 THBS1 THBS2 EYS THBS3 IGFBP5 VCAN ADAMTS17 VWC2L LOXL4 PAPPA FBN3 NPNT | 2.73e-09 | 1026 | 124 | 22 | M5889 |
| Coexpression | NABA_MATRISOME | HSPG2 TMPRSS15 PAMR1 TNC MATN2 CST9L LAMA5 TECTA ADAMTSL3 F7 THBS1 THBS2 THBS3 IGFBP5 VCAN ADAMTS17 VWC2L LOXL4 PAPPA NPNT | 5.65e-08 | 1008 | 124 | 20 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 TNC MATN2 LAMA5 TECTA THBS1 THBS2 THBS3 IGFBP5 VCAN NPNT | 6.84e-08 | 270 | 124 | 11 | MM17057 |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 1.53e-07 | 11 | 124 | 4 | M566 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.31e-07 | 191 | 124 | 9 | MM17059 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 4.88e-07 | 200 | 124 | 9 | M5930 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 1.81e-06 | 121 | 124 | 7 | M12828 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP | 3.23e-06 | 132 | 124 | 7 | MM465 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 3.75e-06 | 135 | 124 | 7 | M5825 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 8.92e-06 | 59 | 124 | 5 | M47993 | |
| Coexpression | NABA_ECM_REGULATORS | 1.83e-05 | 238 | 124 | 8 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 2.06e-05 | 242 | 124 | 8 | MM17062 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | TNC ITGA2 CBLB P3H4 RPL10A THBS1 THBS2 LIMS1 IGFBP5 SUSD2 VCAN PAPPA NOTCH2 | 2.14e-05 | 681 | 124 | 13 | M39175 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST | 2.22e-05 | 71 | 124 | 5 | M45664 | |
| Coexpression | VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1 | 2.79e-05 | 37 | 124 | 4 | M16643 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP | 4.65e-05 | 199 | 124 | 7 | M7414 | |
| Coexpression | ZHU_CMV_24_HR_DN | 5.00e-05 | 84 | 124 | 5 | M4065 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 ZNF148 PHF8 CBLB BLM THBS2 DST ZFYVE9 PTX3 ZNF451 KAT6B PHIP SMAD6 ZNF292 | 5.52e-05 | 856 | 124 | 14 | M4500 |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN | 6.68e-05 | 46 | 124 | 4 | M6679 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN | 7.90e-05 | 48 | 124 | 4 | M1246 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 8.15e-05 | 294 | 124 | 8 | M1804 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C1 | 9.47e-05 | 19 | 124 | 3 | M16026 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | HSPG2 ERBB2 TBC1D9B IPO8 MATN2 THBS2 THBS3 LIMS1 IGFBP5 KAT6B | 1.01e-04 | 482 | 124 | 10 | M12144 |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.11e-04 | 20 | 124 | 3 | MM17053 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 1.26e-04 | 54 | 124 | 4 | M4737 | |
| Coexpression | AIZARANI_LIVER_C25_KUPFFER_CELLS_4 | 1.84e-04 | 174 | 124 | 6 | M39126 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 2.15e-04 | 62 | 124 | 4 | M1576 | |
| Coexpression | GERHOLD_ADIPOGENESIS_DN | 2.43e-04 | 64 | 124 | 4 | MM671 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.51e-04 | 261 | 124 | 7 | M1834 | |
| Coexpression | ZHU_CMV_ALL_DN | 2.59e-04 | 119 | 124 | 5 | M14555 | |
| Coexpression | AIZARANI_LIVER_C31_KUPFFER_CELLS_5 | 2.70e-04 | 120 | 124 | 5 | M39130 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.94e-09 | 199 | 124 | 9 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.35e-08 | 181 | 124 | 8 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 7.14e-08 | 193 | 124 | 8 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.43e-08 | 194 | 124 | 8 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 7.43e-08 | 194 | 124 | 8 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 8.36e-08 | 197 | 124 | 8 | 9a053a32ff9c3a85ef9a3382453acd619cc48546 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.03e-08 | 199 | 124 | 8 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 9.39e-08 | 200 | 124 | 8 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.66e-07 | 168 | 124 | 7 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.87e-07 | 178 | 124 | 7 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.90e-07 | 185 | 124 | 7 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-07 | 185 | 124 | 7 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-07 | 185 | 124 | 7 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.90e-07 | 185 | 124 | 7 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.90e-07 | 185 | 124 | 7 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 9.57e-07 | 187 | 124 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 189 | 124 | 7 | 9e1a51997ef9b6999d9b40cf0a55e561e3b4a84c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-06 | 191 | 124 | 7 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-06 | 192 | 124 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-06 | 195 | 124 | 7 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-06 | 195 | 124 | 7 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-06 | 196 | 124 | 7 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 196 | 124 | 7 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 196 | 124 | 7 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 196 | 124 | 7 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-06 | 197 | 124 | 7 | 3332b9b5bf78f0203ebbd94257a36e9054d896c3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-06 | 198 | 124 | 7 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-06 | 198 | 124 | 7 | cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623 | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-06 | 199 | 124 | 7 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.45e-06 | 199 | 124 | 7 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-06 | 199 | 124 | 7 | f393f8d2b9711e71beb4f1c5e7cac5acb047fd0e | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.45e-06 | 199 | 124 | 7 | fa362f3e456a4853652e52d54e76473809eea76d | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-06 | 200 | 124 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Bronchus_Control_(B.)-Immune-TX-MoAM-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.50e-06 | 200 | 124 | 7 | fe7f8b04067b6680b69c8523f0fa514ef97207e2 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-06 | 200 | 124 | 7 | 4077a85ceb8bb423c06179e16fd870ab95f8a2e8 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-06 | 145 | 124 | 6 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.50e-06 | 153 | 124 | 6 | 65641cc82883716dba0fefb749a30174a63f4da5 | |
| ToppCell | severe-CD4+_T_naive|World / disease stage, cell group and cell class | 5.22e-06 | 157 | 124 | 6 | ccf9abe0b59e9ea728cec4bba1872ffe14c7385c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.47e-06 | 163 | 124 | 6 | 8d2b2119c6b3d5b677da6f377fd85146590e1246 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-D|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.47e-06 | 163 | 124 | 6 | acfb2ece6202479e615d54fd3ecb8b4a571b5a18 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intermediate_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 6.94e-06 | 165 | 124 | 6 | c3fa9225d2f9c9e821d4fbd2315fcc98ce1f1c55 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.18e-06 | 166 | 124 | 6 | 28a44448a0b0d72459e8fe84ce5d666f16f514b3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.18e-06 | 166 | 124 | 6 | 2a04915d534a83e65aa168435d6856125b5bdd78 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-06 | 169 | 124 | 6 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.80e-06 | 172 | 124 | 6 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-05 | 176 | 124 | 6 | 56e19240f4a7b617a986e3c0854b757394e78251 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-05 | 176 | 124 | 6 | c88b46fe29ae7606c8880a6ff0ebb85c0dfda8bd | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-05 | 177 | 124 | 6 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 180 | 124 | 6 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 180 | 124 | 6 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 181 | 124 | 6 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 181 | 124 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 182 | 124 | 6 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 182 | 124 | 6 | 9966f42c338cbd471efa8ffc765a6ce93693aa75 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-05 | 183 | 124 | 6 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.29e-05 | 184 | 124 | 6 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.29e-05 | 184 | 124 | 6 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 184 | 124 | 6 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 185 | 124 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-05 | 185 | 124 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.37e-05 | 186 | 124 | 6 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.41e-05 | 187 | 124 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-05 | 187 | 124 | 6 | 3b1439018e265a61d9599e307a202e3c2f60ed32 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.41e-05 | 187 | 124 | 6 | e99bc27d212c74da37770297122a4b30445ccd0d | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 187 | 124 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 187 | 124 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 187 | 124 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.46e-05 | 188 | 124 | 6 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-05 | 188 | 124 | 6 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 1.50e-05 | 189 | 124 | 6 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.50e-05 | 189 | 124 | 6 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.50e-05 | 189 | 124 | 6 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 189 | 124 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-05 | 190 | 124 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-05 | 190 | 124 | 6 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 190 | 124 | 6 | c7bd087f36321cec61b98657433b4d19d135791f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 190 | 124 | 6 | 834218fcc59df5e7e52de154272f3d55d81d0dac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.55e-05 | 190 | 124 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 7f6dafd5418764d67f6d5ec2153233b791910e81 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 191 | 124 | 6 | f5ce33af56178333730be308253943c54a0724cf | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.59e-05 | 191 | 124 | 6 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 191 | 124 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 191 | 124 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.59e-05 | 191 | 124 | 6 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 191 | 124 | 6 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 124 | 6 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 124 | 6 | b35f0e422070ba9c7c1d9ff3eace4edc10286cde | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 192 | 124 | 6 | a8b7c539dc3037071bf068f372e4215563e11de4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 192 | 124 | 6 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-05 | 192 | 124 | 6 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.64e-05 | 192 | 124 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 192 | 124 | 6 | 2143e1fad2e88b90d668e12af37b2092d379090f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 192 | 124 | 6 | 904c003c4f73b1dfc8243cee02aad2676c515e50 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-05 | 193 | 124 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.69e-05 | 193 | 124 | 6 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-05 | 193 | 124 | 6 | 3d85c28f6ebdcb15e875ad01d52d6c138fbf8525 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-05 | 193 | 124 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-05 | 193 | 124 | 6 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| Computational | Genes in the cancer module 412. | 8.87e-05 | 13 | 75 | 3 | MODULE_412 | |
| Drug | vinylene | EVC2 ZNF148 ZFP28 ITGA2 RNF114 ZNF496 APOBEC3F ZNF263 LIMS1 ZNF277 ZNF335 PRDM15 | 1.01e-08 | 245 | 124 | 12 | CID000006326 |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A | 6.13e-07 | 179 | 124 | 9 | 4554_DN | |
| Drug | LMWH | HSPG2 ERBB4 TNC LAMA5 F7 THBS1 THBS2 THBS3 DST OXT IGFBP5 PTX3 VCAN LRP2 PAPPA | 3.33e-06 | 663 | 124 | 15 | CID000000772 |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.06e-05 | 192 | 124 | 8 | 2947_DN | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A | 1.23e-05 | 196 | 124 | 8 | 4372_UP | |
| Drug | kalinin | 1.24e-05 | 55 | 124 | 5 | CID000032518 | |
| Drug | A-state | 1.29e-05 | 9 | 124 | 3 | CID005460479 | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.32e-05 | 198 | 124 | 8 | 2809_DN | |
| Drug | Suprofen [40828-46-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 1.32e-05 | 198 | 124 | 8 | 3343_UP | |
| Disease | stomach carcinoma (is_marker_for) | 2.60e-06 | 24 | 120 | 4 | DOID:5517 (is_marker_for) | |
| Disease | anorexia nervosa | 1.00e-05 | 70 | 120 | 5 | MONDO_0005351 | |
| Disease | functional brain measurement | 2.17e-05 | 82 | 120 | 5 | EFO_0007849 | |
| Disease | Malignant neoplasm of breast | AKAP6 ERBB2 ERBB4 TBC1D9B TECTA THBS1 FASN THBS3 IGFBP5 ZNF277 ADGRF4 KAT6B NOTCH2 SORL1 ZNF646 | 3.15e-05 | 1074 | 120 | 15 | C0006142 |
| Disease | vital capacity | HSPG2 RIN3 IPO8 PRDM5 ADAMTSL3 PPP1CA TXNL1 ZNF263 THBS1 THBS2 DST ADAMTS17 LRP2 FBN3 SMAD6 NPNT | 4.20e-05 | 1236 | 120 | 16 | EFO_0004312 |
| Disease | lung adenocarcinoma (is_implicated_in) | 4.78e-05 | 49 | 120 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Malignant neoplasm of skin | 9.96e-05 | 59 | 120 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 9.96e-05 | 59 | 120 | 4 | C0037286 | |
| Disease | myotonic dystrophy type 2 (implicated_via_orthology) | 1.63e-04 | 5 | 120 | 2 | DOID:0050759 (implicated_via_orthology) | |
| Disease | colorectal health | 1.78e-04 | 201 | 120 | 6 | EFO_0008460 | |
| Disease | peak expiratory flow | 2.07e-04 | 498 | 120 | 9 | EFO_0009718 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.98e-04 | 32 | 120 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Disseminated Intravascular Coagulation | 3.40e-04 | 7 | 120 | 2 | C0012739 | |
| Disease | head and neck squamous cell carcinoma (is_marker_for) | 4.52e-04 | 8 | 120 | 2 | DOID:5520 (is_marker_for) | |
| Disease | carpal tunnel syndrome | 4.87e-04 | 89 | 120 | 4 | EFO_0004143 | |
| Disease | Mental deterioration | 5.80e-04 | 9 | 120 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 5.80e-04 | 9 | 120 | 2 | C1270972 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 6.25e-04 | 41 | 120 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 6.25e-04 | 41 | 120 | 3 | C0858252 | |
| Disease | Leukemia, Myelocytic, Acute | 7.24e-04 | 173 | 120 | 5 | C0023467 | |
| Disease | cancer (implicated_via_orthology) | 8.17e-04 | 268 | 120 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | gallbladder neoplasm | 8.81e-04 | 11 | 120 | 2 | C0016978 | |
| Disease | Malignant neoplasm of gallbladder | 8.81e-04 | 11 | 120 | 2 | C0153452 | |
| Disease | homostachydrine measurement | 1.24e-03 | 13 | 120 | 2 | EFO_0021164 | |
| Disease | hyperglycemia (is_marker_for) | 1.24e-03 | 13 | 120 | 2 | DOID:4195 (is_marker_for) | |
| Disease | median neuropathy (biomarker_via_orthology) | 1.45e-03 | 14 | 120 | 2 | DOID:571 (biomarker_via_orthology) | |
| Disease | Impaired cognition | 1.45e-03 | 14 | 120 | 2 | C0338656 | |
| Disease | forced expiratory volume | 1.46e-03 | 789 | 120 | 10 | EFO_0004314 | |
| Disease | colorectal cancer (is_implicated_in) | 1.53e-03 | 121 | 120 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | tumor necrosis factor beta measurement | 1.66e-03 | 15 | 120 | 2 | EFO_0008308 | |
| Disease | creatine kinase measurement | 1.81e-03 | 59 | 120 | 3 | EFO_0004534 | |
| Disease | RS-warfarin measurement | 1.88e-03 | 128 | 120 | 4 | EFO_0803325 | |
| Disease | developmental dysplasia of the hip | 1.90e-03 | 16 | 120 | 2 | EFO_1000648 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.90e-03 | 16 | 120 | 2 | C0038015 | |
| Disease | Diabetic Angiopathies | 1.90e-03 | 16 | 120 | 2 | C0011875 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.90e-03 | 16 | 120 | 2 | C3541456 | |
| Disease | Microangiopathy, Diabetic | 1.90e-03 | 16 | 120 | 2 | C0025945 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.90e-03 | 16 | 120 | 2 | C4551479 | |
| Disease | triiodothyronine measurement | 1.90e-03 | 16 | 120 | 2 | EFO_0008392 | |
| Disease | Schwartz-Jampel Syndrome | 1.90e-03 | 16 | 120 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.90e-03 | 16 | 120 | 2 | C0025237 | |
| Disease | Benign neoplasm of stomach | 2.14e-03 | 17 | 120 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.14e-03 | 17 | 120 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.14e-03 | 17 | 120 | 2 | C0154060 | |
| Disease | Van Buchem disease | 2.14e-03 | 17 | 120 | 2 | C0432272 | |
| Disease | Colorectal Carcinoma | 2.33e-03 | 702 | 120 | 9 | C0009402 | |
| Disease | Intellectual Disability | 2.40e-03 | 447 | 120 | 7 | C3714756 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.54e-03 | 139 | 120 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 2.61e-03 | 140 | 120 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.67e-03 | 141 | 120 | 4 | C0005684 | |
| Disease | Phenyllactate (PLA) measurement | 2.68e-03 | 19 | 120 | 2 | EFO_0021662 | |
| Disease | laryngeal squamous cell carcinoma (is_marker_for) | 2.68e-03 | 19 | 120 | 2 | DOID:2876 (is_marker_for) | |
| Disease | Osteochondrodysplasias | 2.68e-03 | 19 | 120 | 2 | C0029422 | |
| Disease | carotid artery disease (is_marker_for) | 2.68e-03 | 19 | 120 | 2 | DOID:3407 (is_marker_for) | |
| Disease | Dyschondroplasias | 2.68e-03 | 19 | 120 | 2 | C0013366 | |
| Disease | Multiple Epiphyseal Dysplasia | 2.97e-03 | 20 | 120 | 2 | C0026760 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 3.07e-03 | 71 | 120 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | family history of Alzheimer’s disease | 3.07e-03 | 71 | 120 | 3 | EFO_0009268 | |
| Disease | stomach cancer (is_implicated_in) | 3.19e-03 | 72 | 120 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | Stomach Carcinoma | 3.27e-03 | 21 | 120 | 2 | C0699791 | |
| Disease | migraine disorder, endometriosis | 3.32e-03 | 73 | 120 | 3 | EFO_0001065, MONDO_0005277 | |
| Disease | melanoma | 3.51e-03 | 248 | 120 | 5 | C0025202 | |
| Disease | Malignant neoplasm of prostate | 3.75e-03 | 616 | 120 | 8 | C0376358 | |
| Disease | Paroxysmal atrial fibrillation | 3.84e-03 | 156 | 120 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.84e-03 | 156 | 120 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.84e-03 | 156 | 120 | 4 | C2585653 | |
| Disease | Immunologic Deficiency Syndromes | 3.92e-03 | 23 | 120 | 2 | C0021051 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| THSCVDLDDKGCPAE | 631 | P04626 | |
| SHFKDGPNCVEKCPD | 581 | Q15303 | |
| LDFDECHSNPCRNGA | 3126 | P13611 | |
| DCNEKNGCHESEPSV | 776 | Q9P2K8 | |
| NCSQPCAKDFHGEIG | 61 | Q8IZF3 | |
| VFCPHCGEDASEAQE | 531 | Q96KQ7 | |
| DTERCFDCPHGDKVH | 446 | A6NK59 | |
| AGFAGPRCEHDLDDC | 381 | Q9NYJ7 | |
| KFQCEGSETHLALCP | 861 | Q9NR16 | |
| ELSPDGKNCVDHNEC | 521 | Q75N90 | |
| HCLCQDGFELTADGK | 1911 | Q75N90 | |
| HCEFPPCDESSDFKE | 776 | Q96MT7 | |
| DFCVHKDEPCDTVGI | 346 | Q8TE56 | |
| CRDGFKGDLCEHEEN | 4131 | P98160 | |
| PFEKNCGADHICQDN | 766 | P20702 | |
| THTGEKPFQCDVCDL | 566 | Q9NQX1 | |
| EEGKDNHCFKNADPC | 1206 | Q8WYB5 | |
| PCEHAGKCVNTDGAF | 426 | Q04721 | |
| GHKASFCLEDTNCPT | 636 | Q96JB6 | |
| EDDQHKIPCHCGAVN | 4891 | Q8NEZ4 | |
| SDEANCDKKTCGPHE | 3466 | Q9NZR2 | |
| GGHCIINKDSEDIFC | 4366 | Q9NZR2 | |
| GSPLEEKHDQCKCEN | 906 | O00339 | |
| FPHEGTKEICANGCS | 526 | Q5T1H1 | |
| DIDECASHPCKNGAT | 681 | Q5T1H1 | |
| STKCHGCDFPVEAGD | 666 | O75112 | |
| AKDDPGVLVHSCNFD | 411 | Q6UXI9 | |
| CHAEFDGNTAIKECL | 2026 | Q03001 | |
| SSFNKCHCGEPEHEE | 2066 | Q03001 | |
| EPCKADHFQCKNGEC | 641 | P98073 | |
| CAENDKDVKIEPCGH | 376 | Q13191 | |
| TFKANQGDEACTHCP | 276 | P29323 | |
| SLDCLNQDCGDHKSE | 376 | P34910 | |
| VECCHFKTAVEAPLG | 86 | Q86UK5 | |
| CKEGEDEHPQCLNSQ | 156 | Q8N423 | |
| LGSFVHCEPCDEKAL | 21 | P24593 | |
| HLDDCLDNSDEKGCG | 3096 | P98164 | |
| VDEATCAACDFNKPG | 646 | Q07864 | |
| EECNNAHASVCPKHG | 176 | Q9NQV6 | |
| NSFAHLPDCKGDQSE | 141 | Q14749 | |
| VCHGHADACDAKDPT | 301 | O15230 | |
| ISKIGDENCDPECNH | 416 | Q13219 | |
| LNKVCHGDCEDVFLD | 1476 | Q8NDA8 | |
| EGLPVDESDSCCFQH | 106 | Q02509 | |
| FSIPFHKDCGEDGLC | 781 | P17301 | |
| DEKIFCCHGGLSPDL | 166 | P62136 | |
| CPDCVAKLAEFLAEH | 96 | Q8IUX4 | |
| NPDFCKKHPDVSCDN | 1051 | P54132 | |
| CTVKSCDDFLGQLPH | 1706 | P17927 | |
| SGDPYCEKDAQEVHC | 366 | P43251 | |
| GTCSRADADCKFAHP | 26 | Q9NUK0 | |
| NSDDESPECCHVKPA | 101 | Q96QF7 | |
| GKHCELNIDECFSNP | 1171 | P82279 | |
| TRCGKFEDDIDNCHF | 96 | Q9H4G1 | |
| KFCFTPHTEEGCLSE | 1116 | P49327 | |
| DDHKDFDCNTRQPGC | 46 | O95377 | |
| HGEPCNFSDKEVEDC | 96 | P07358 | |
| CHDPVCKAENFKSDC | 446 | Q96LW4 | |
| SSPCFHDGTCVLDKA | 241 | Q6UXH9 | |
| PCACGQEHSEWDKLF | 46 | P26022 | |
| CFQLADDALPHCIKG | 931 | Q8TB24 | |
| LCGDAGEDAECHAAK | 726 | O15397 | |
| AQEAAKLCGDDHFCN | 676 | Q9UGT4 | |
| KLCGDDHFCNFDVAA | 681 | Q9UGT4 | |
| AFAGCSQDPEFHKVC | 1311 | Q92673 | |
| EVADHPKRFSADCCV | 461 | Q8WV44 | |
| CHPTRCGEFEKNNPD | 76 | Q6P1N9 | |
| LKPLCGCHSFAAAAD | 241 | O43541 | |
| FCLPAFEGRNCETHK | 131 | P08709 | |
| DGHPVCFDTSNEDDC | 466 | P57071 | |
| SPDGCHADPACDAEA | 106 | P01178 | |
| KGDFRAQENVPSCCH | 1346 | Q6ZUB1 | |
| PDHFNCANCGKELTA | 156 | P48059 | |
| GPPAACDAHQCDDAE | 536 | O60287 | |
| CFASKEEDACHLIIP | 331 | Q66K14 | |
| CEPDVFHQKDAEDCS | 2041 | Q13023 | |
| GHLAKDCDLQEDACY | 61 | P62633 | |
| TSQCVPLHKCGCDFD | 641 | O75443 | |
| QSTHTGEKPFGCEEC | 251 | P17039 | |
| ECPECGKAFTHQSNL | 241 | Q6P2D0 | |
| GKFPEQAHSSACDAL | 461 | Q8N5D0 | |
| CGTCTKAFHDPESAQ | 791 | Q9Y4E5 | |
| DCIDCGKAFSDHIGL | 506 | Q8NHY6 | |
| NFHDSDCEPKGSSPC | 96 | Q8NBP0 | |
| CFKSDPPQCHTDQDC | 41 | Q8WWY7 | |
| ECKEVPDACFNHNGE | 591 | P07996 | |
| HSEEKPFDCVDCGKA | 351 | P17023 | |
| PFDCVDCGKAFSAQE | 356 | P17023 | |
| AVFDCKCSPDGQHFA | 516 | Q8WWQ0 | |
| CPEKNFDQEGLVEHC | 146 | Q9Y508 | |
| EDGSGECEVFCKNHP | 411 | O95757 | |
| CLAGCEGAHEQVDFK | 241 | Q92791 | |
| HCLSDAEGDFSDPCA | 341 | Q2MJR0 | |
| HDGFAGDDCNKPLCL | 271 | P24821 | |
| DTCNDLCHPGFQERK | 976 | O60281 | |
| HKAETELDFACDQCG | 546 | Q8N554 | |
| DAQTFACPDCGKAFE | 1581 | O15015 | |
| ACPDCGKAFESHQEL | 1586 | O15015 | |
| GCQHVVEFDFLGKDC | 356 | Q969P6 | |
| PFDCIDCGKAFTDHI | 396 | Q6ECI4 | |
| KRILFCTDNCPDHGD | 451 | O60813 | |
| DINECAHADPCFPGS | 316 | P49746 | |
| DEKIFCCHGGLSPDL | 166 | P36873 | |
| PKFSVCVLGDQQHCD | 61 | P62906 | |
| CFPHSKGCNDENNLP | 231 | Q8N9V7 | |
| EQSKDGNEPRECAHC | 631 | Q8IYT8 | |
| QEKPHECSVCGELFS | 431 | Q96IT1 | |
| EEHPASAVCLFCEKQ | 296 | Q9NRM2 | |
| EHNGCCPECKEVKNF | 101 | B2RUY7 | |
| ECGKAFCESADLIQH | 371 | Q08ER8 | |
| HICEECGKAFSLPSN | 716 | Q86WZ6 | |
| GERPFHCTLCEKAFN | 1746 | Q9UL36 | |
| EKAADIDLYHCPNCE | 76 | Q9UPP1 | |
| HTNEPLFKCTQEGCG | 156 | Q92664 | |
| PCNECGKAFSHISAL | 126 | P0CG24 | |
| CNECGKAFSHTPAFI | 211 | P0CG24 | |
| PHECDECGKLFSNKS | 216 | Q13106 | |
| FIHTGEKPFQCSQCD | 191 | Q9UQR1 | |
| FLGNGTHCEDLDECA | 581 | P35442 | |
| FAHCTFTGNESKPLC | 926 | Q7Z2W7 | |
| IHTGEKPFTCEECGN | 216 | B4DXR9 | |
| PIEHHFACKECGDTF | 96 | Q9NSD4 | |
| SHEAGDPQLFKCLQC | 486 | Q9H4Z2 | |
| HSAERPFECEECGKA | 431 | Q9BR84 | |
| ECSDCGKAFNDPSAL | 251 | Q96PQ6 | |
| KNLDTGHPVFFCNDC | 961 | Q6ZSZ6 | |
| GGACFNEKADSHLVC | 1161 | O95405 | |
| THTGEKPFQCEFEGC | 356 | O95409 | |
| HAGEKPFACNECGKA | 191 | Q96NJ6 | |
| NKAGCECLNESDEHG | 131 | O43396 | |
| KCPECGEIFAHSSNL | 491 | O14978 | |
| KTCSNHDCPPDAEDF | 116 | P82987 |